Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells.

This publication has 17 references indexed in Scilit:

• Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.
  Proceedings of the National Academy of Sciences, 1983
• Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine
  Antimicrobial Agents and Chemotherapy, 1983
• Activation by thymidine kinase and potent antiherpetic activity of 2′-nor-2′-deoxyguanosine (2′NDG)
  Biochemical and Biophysical Research Communications, 1982
• Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases
  Antimicrobial Agents and Chemotherapy, 1981
• Herpes simplex virus type I DNA polymerase. Kinetic properties of the associated 3‘-5‘ exonuclease activity and its role in araAMP incorporation.
  Journal of Biological Chemistry, 1981
• Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy
  Antimicrobial Agents and Chemotherapy, 1980
• (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.
  Proceedings of the National Academy of Sciences, 1979
• Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides
  Journal of Medicinal Chemistry, 1979
• Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine
  Proceedings of the National Academy of Sciences, 1977
• A RATIONAL APPROACH TO THE DEVELOPMENT OF ANTIVIRAL CHEMOTHERAPY: ALTERNATIVE SUBSTRATES OF HERPES SIMPLEX VIRUS TYPE 1 (HSV‐1) AND TYPE 2 (HSV‐2) THYMIDINE KINASE (TK) *
  Annals of the New York Academy of Sciences, 1977